Clinical Trial Update: Phase 2 Study of EPI-743 for Treatment of Rett Syndrome [Phase 2]

View source ↗

Summary

Phase 2 study of EPI-743 for Rett syndrome has completed, with the trial status listed as COMPLETED on ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• EPI-743

Snippet

Sponsor: Edison Pharmaceuticals Inc | Conditions: Rett Syndrome | Phase 2 | Status: COMPLETED